Stanford University
Showing 2,801-2,850 of 2,876 Results
-
Regan Murphy Kao
Director, East Asia Library, East Asia Library
Current Role at StanfordDirector, East Asia Library
-
Andrea Murray
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioAndrea Murray, MD is currently a Clinical Associate Professor for the Department of Anesthesia, Perioperative and Pain Medicine at Stanford University and is board-certified in Pediatric Anesthesiology, Internal Medicine, and in Pediatrics. Her interests include sustainable models in global health, regional anesthesia, simulation, and immersive technology for reduction of perioperative anxiety. She is deeply passionate about medical education and is dedicated to mentoring the next generation of physicians.
-
Laura Clark Murray
Program Manager for High Impact Technology (HIT) Fund, Office of Technology Licensing (OTL)
BioLaura joined OTL in 2022 to launch the High Impact Technology (HIT) Fund and Program. She has led product marketing management, project management, and operations efforts for Apple, Electronic Arts, and for numerous startups.
-
Lucas Murray
Postdoctoral Scholar, Biochemistry
Current Research and Scholarly InterestsI use single-molecule tools and approaches to study the assembly and function of molecular machines. I currently am working to understand the interplay between genome structure and kinetochore assembly and function in vertebrates.
-
Tiffany Murray
Executive Associate to Russ B. Altman, MD, PhD & Teri E. Klein, PhD, Bioengineering
Current Role at StanfordExecutive Associate to
Russ B. Altman, MD, PhD
The Kenneth Fong Professor of Engineering
Professor, Bioengineering, Genetics, Medicine, Biomedical Data Science and, by courtesy, of Computer Science
Teri E. Klein, PhD
Professor, Biomedical Data Science & Medicine and, by courtesy, of Genetics -
Walter Murray
Professor (Research) of Management Science and Engineering, Emeritus
BioProfessor Murray's research interests include numerical optimization, numerical linear algebra, sparse matrix methods, optimization software and applications of optimization. He has authored two books (Practical Optimization and Optimization and Numerical Linear Algebra) and over eighty papers. In addition to his University work he has extensive consulting experience with industry, government, and commerce.
-
Marley Murrell
Ph.D. Student in Education, admitted Autumn 2024
Graduate Assistant for Community Engagement, Haas Center for Public ServiceBioMarley Murrell, proudly from Tucson, Arizona, is a PhD student in the Curriculum and Teacher Education (CTE) program at Stanford University. She is also working on her PhD Minor in Comparative Studies in Race and Ethnicity (CSRE). Her scholarship is being supported by the Enhancing Diversity in Graduate Education (EDGE) Fellowship. Her current research interest are within mathematics education looking at teacher learning, professional development, and mathematics anxiety.
Prior to her studies at Stanford, Marley earned her Bachelors of Science in Mathematics with an emphasis in Education from the University of Arizona. While teaching, she earned her Master of Science in Mathematics Education from Northern Arizona University. In her teaching career she taught Algebra, Cambridge Algebra, Geometry, Cambridge Geometry, AVID 9, and Dual Enrollment College Algebra all at Amphitheater High School, her alma matter. As a high school teacher, she founded and ran the schools Girls Powerlifting Club. She also coached the school's Color Guard. -
Adam J. Murrietta, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Adam J. Murrietta is a fellowship-trained orthopaedic surgeon with Stanford Health Care. He is also a clinical assistant professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine.
Dr. Murrietta diagnoses and treats a wide range of bone and joint conditions, including arthritis, bursitis, fractures, and infections. As an orthopaedic surgeon, he specializes in joint replacement surgery, with a focus on hip and knee replacements. He has advanced expertise in minimally invasive techniques, robotic-assisted procedures, and outpatient joint replacement. Additionally, Dr. Murrietta has extensive training in the latest surgical technologies and uses these innovations to reduce pain and enhance outcomes for his patients.
Dr. Murrietta’s research focuses on improving surgical outcomes and the treatment and management of orthopaedic injuries. His ongoing work focuses on joint replacement techniques and patient-reported outcomes. His research has been published in peer-reviewed journals, including The Journal of Arthroplasty, The Bone & Joint Journal, and Journal of the American Academy of Orthopaedic Surgeons. He has also presented his findings at regional and national conferences, including annual meetings of the Western Orthopaedic Association and the American Association of Hip and Knee Surgeons.
Dr. Murrietta is a fellow of the American Association of Hip and Knee Surgeons (AAHKS) and the American Academy of Orthopaedic Surgeons (AAOS). He is also a member of the American Medical Association (AMA) and the Western Orthopaedic Association (WOA). -
Mark Musen
Stanford Medicine Professor of Biomedical Informatics Research, Professor of Medicine (Computational Medicine) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Mete Muslu
Postdoctoral Scholar, Electrical Engineering
BioA. Mete Muslu received his B.Sc. and M.Sc. degrees in Mechanical Engineering from Ozyegin University, Istanbul, Turkey, in 2018 and 2020, respectively, and his Ph.D. in Mechanical Engineering from the Georgia Institute of Technology, Atlanta, GA, USA, in 2025. His doctoral research focused on developing single- and two-phase cooling solutions for integrated power electronics packages and multi-functional cold plates. His current research interests include understanding device-level multi-physics and developing integrated thermal management solutions spanning from the chip to the package level for high-performance computing and power applications.
-
Adel Mutahar
Postdoctoral Scholar, General and Vascular Surgery
BioDr. Adel Z. I. Mutahar is a postdoctoral researcher in the Department of Surgery at Stanford University, working under the mentorship of Dr. Frederick M. Dirbas. His research focuses on translational breast cancer biology and emerging radiotherapy technologies, with an emphasis on tumor–microenvironment interactions, immuno-oncology, and preclinical therapeutic development. His academic journey spans three countries—beginning in Yemen, advancing through India, and now progressing at Stanford—reflecting his commitment to impactful cancer research and global scientific advancement.
Dr. Mutahar began his career in Yemen, earning his Bachelor’s degree in Medical Laboratory Sciences before joining Abs Community College as a faculty member. From 2007–2013, he held several academic leadership roles, including Academic Director, Head of Evaluation, and Assistant Dean of Students, where he modernized curriculum, expanded hands-on diagnostic training, and strengthened laboratory education infrastructure in resource-limited settings. His work contributed to building a more skilled medical diagnostics workforce and improving pathways for laboratory science education.
Awarded a prestigious national merit scholarship, Dr. Mutahar continued his graduate and doctoral training in India, completing his M.S. and Ph.D. in Biotechnology with a focus on triple-negative breast cancer. During his doctoral work, he developed 3D tumor spheroid models and combinatorial therapeutic strategies, demonstrating synergy between anti-angiogenic agents and chemotherapy in TNBC. He further advanced this research by creating an orthotopic murine model to investigate metastatic progression and demonstrated that knockdown of the MTA1 gene in mesenchymal stem cells (MSCs) significantly suppressed TNBC invasion, angiogenesis, and metastatic spread, introducing a promising stromal-targeted therapeutic concept for aggressive breast cancer. This work earned recognition through travel grants, conference presentations, and a Best Poster Award. His scientific adaptability was further demonstrated during the COVID-19 pandemic, when he uncovered a novel interaction between SARS-CoV-2 Spike RBD and VEGF signaling.
At Stanford, his work emphases on FLASH radiotherapy, an ultrahigh-dose-rate modality with the potential to widen the therapeutic window by minimizing normal-tissue toxicity while maintaining tumor control. Working within Dr. Dirbas’s translational breast oncology program, Dr. Mutahar employs patient-derived xenografts, orthotopic murine models, spatial transcriptomics, single-cell RNA sequencing, and immune profiling to dissect the biological mechanisms governing treatment response. His research integrates multi-omics analysis to map early and late radiotherapy injury pathways—including senescence, apoptosis and fibrosis. His goal is to develop mechanism-driven radio-immunotherapy strategies and durable FLASH-RT combination regimens that can be translated into clinical trials for breast cancer, improving therapeutic durability, minimizing toxicity, and ultimately enhancing patient outcomes.
Dr. Mutahar’s long-term vision is to establish an independent laboratory at the intersection of radiobiology, immuno-oncology, and translational therapeutics. Guided by Dr. Dirbas’s mentorship and shaped by multidisciplinary experience across three continents, he aims to develop biologically informed treatment strategies that eradicate tumors while preserving normal tissue and immune integrity—ultimately improving quality of life and survival for women with aggressive breast cancers.
